Laura E Pope Selected Research

Quinidine (Chinidin)

1/2017	Trial of dextromethorphan/quinidine to treat levodopa-induced dyskinesia in Parkinson's disease.
11/2014	An open-label multicenter study to assess the safety of dextromethorphan/quinidine in patients with pseudobulbar affect associated with a range of underlying neurological conditions.
2/2012	Efficacy and safety of dextromethorphan/quinidine at two dosage levels for diabetic neuropathic pain: a double-blind, placebo-controlled, multicenter study.
10/2006	Dextromethorphan and quinidine in adult patients with uncontrolled painful diabetic peripheral neuropathy: a 29-day, multicenter, open-label, dose-escalation study.
5/2006	Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laura E Pope Research Topics

Disease

2	Multiple Sclerosis 11/2014 - 05/2006
2	Peripheral Nervous System Diseases (PNS Diseases) 02/2012 - 10/2006
2	Pain (Aches) 02/2012 - 10/2006
2	Body Weight (Weight, Body) 08/2002 - 08/2002
1	Dyskinesias (Dyskinesia) 01/2017
1	Parkinson Disease (Parkinson's Disease) 01/2017
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 11/2014
1	Neuralgia (Stump Neuralgia) 02/2012
1	Chromosome Aberrations (Chromosome Abnormalities) 08/2002

Drug/Important Bio-Agent (IBA)

5	Quinidine (Chinidin)FDA LinkGeneric 01/2017 - 05/2006
5	Dextromethorphan (Racemethorphan)FDA LinkGeneric 01/2017 - 05/2006
2	NAD (NADH)IBA 02/2012 - 10/2006
2	docosanol (IK.2)FDA Link 08/2002 - 08/2002
1	Sigma-1 ReceptorIBA 01/2017
1	Levodopa (L Dopa)FDA LinkGeneric 01/2017
1	Fatty AlcoholsIBA 08/2002

Therapy/Procedure

1	Ambulatory Care (Outpatient Care) 02/2012
1	Glycemic Control 10/2006
1	Therapeutics 10/2006